The efficacy of voxelotor, 900 mg in patients with sickle cell anaemia: A meta-analysis of the randomised controlled trials
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, vol.75, no.6, 2021 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 75 Issue: 6
- Publication Date: 2021
- Doi Number: 10.1111/ijcp.13967
- Journal Name: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
- Inonu University Affiliated: Yes
Abstract
Objective Sickle cell anaemia (SCA), an inherited chronic hematological disease affecting hundreds of thousand people worldwide, causes significant morbidity and reduced life expectancy about two or three decades. This study aimed to conduct a meta-analysis of the efficacy of voxelotor, 900 mg in patients with SCA.